Failure-to-Update Claim Not Viable; Dismissal of Generic Drug Maker Affirmed

Litigation & Dispute Resolution partner Hank Bullock and associate Andrew Calica (both New York) are mentioned as representing Schwarz Pharma Inc. in an article reporting that an Iowa appeals court affirmed that a user of generic Reglan can hold neither brand-name nor generic manufacturers of the digestion drug liable for her involuntary movement disorder.